Scientific article

Nouveautés en médecine 2006 : Psychiatrie

Published inRevue médicale suisse, vol. 3, no. 94, p. 161-167
Publication date2007

Introduced this year on the Swiss market, duloxetine (Cymbalta) is a new antidepressant which inhibits the reuptake of noradrenaline and serotonin. Clinical studies have shown its efficacy in depression as well as in neuropathic pains (60-120 mg/day) with a good tolerability. In this paper are also included short reviews about the two large American studies developed by the National Institute of Mental Health in the fields of the treatment for depression (STAR-D) and of the antipsychotic treatments for schizophrenia (CATIE study). Its also reviews two questions of present interest: the use of the second generation antipsychotics for the treatment of bipolar depression and the concept of bipolar disorders in children.

  • Adolescent
  • Antidepressive Agents/therapeutic use
  • Bipolar Disorder/drug therapy
  • Child
  • Depression/drug therapy
  • Humans
  • Mental Disorders/drug therapy
  • Schizophrenia/drug therapy
  • Thiophenes/therapeutic use
Citation (ISO format)
AUBRY, Jean-Michel et al. Nouveautés en médecine 2006 : Psychiatrie. In: Revue médicale suisse, 2007, vol. 3, n° 94, p. 161–167.
Main files (2)
Article (Published version)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/10/2014 10:53:00 AM
First validation12/10/2014 10:53:00 AM
Update time03/14/2023 10:38:36 PM
Status update03/14/2023 10:38:36 PM
Last indexation01/16/2024 3:44:23 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack